Clearmind Medicine Inc. (CMND) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Clearmind Medicine Inc. (CMND) closed at USD 6.42 on 2026-10-15, a change of -99.8 % over the past year, with a market capitalization of USD 3.18M.

Clearmind Medicine Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Clearmind Medicine Inc. key figures

Previous close

USD 6.42 (2026-10-15)

1-year change

-99.8 %

Market cap

USD 3.18M

Enterprise value

USD -11.5M

P/E ratio (trailing)

-0.01

P/E ratio (forward)

n/a

EPS (trailing)

-461.20

EPS (forward)

n/a

PEG ratio

n/a

Price to book

0.13

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.01

Employees

n/a

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Clearmind Medicine Inc.

Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. It develops MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as well as an alcohol substitute consumer product; and CM-CMND-001 which is in Phase I/IIa clinical trial for the treatment of alcohol use disorder. In addition, the company has a strategic collaboration with SciSparc Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem, Polyrizon Ltd., and NeuroThera Labs Inc. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Clearmind Medicine Inc. and compare it with other stocks.